Advaxis Inc. [NASDAQ: ADXS] traded at a high on 08/04/20, posting a 0.28 gain after which it closed the day’ session at $0.57. The company report on August 3, 2020 that Advaxis Announces Common Stock Purchase Agreement for up to $20 Million with Lincoln Park Capital.
Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announced that it has entered into a common stock purchase agreement for up to $20 million with Lincoln Park Capital Fund, LLC (LPC), a Chicago-based institutional investor. Upon execution of the purchase agreement, Lincoln Park made an initial purchase of $2 million of common stock at $0.57 per share.
Under the terms of the purchase agreement, Advaxis will have the right at its sole discretion, but not the obligation, to sell to LPC up to $20 million worth of shares over the 36-month term of the agreement, subject to certain conditions. There are no upper limits to the price per share LPC may pay to purchase the shares, and the purchase price of the shares will be based on the prevailing market prices at the time of each sale to LPC. Advaxis controls the timing and amount of any future sales of its stock to LPC.
The results of the trading session contributed to over 1047277 shares changing hands. Over the past one week, the price volatility of Advaxis Inc. stands at 6.26% while the volatility over the past one month is 6.66%.
The market cap for ADXS stock reached $36.25 million, with 60.57 million shares outstanding and 52.71 million shares in the current float. Compared to the average trading volume of 1.24M shares, ADXS reached a trading volume of 1047277 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Advaxis Inc. [ADXS]?
Barclays have made an estimate for Advaxis Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on August 03, 2016. While these analysts kept the previous recommendation, Barclays raised their target price to Overweight. The new note on the price target was released on September 22, 2015, representing the official price target for Advaxis Inc. stock. Previously, the target price had yet another raise to $30, while Guggenheim analysts kept a Buy rating on ADXS stock. On June 16, 2015, analysts increased their price target for ADXS shares from 25 to 30.
The Average True Range (ATR) for Advaxis Inc. is set at 0.04, with the Price to Sales ratio for ADXS stock in the period of the last 12 months amounting to 120.84. The Price to Book ratio for the last quarter was 0.97, with the Price to Cash per share for the same quarter was set at 0.45.
How has ADXS stock performed recently?
Advaxis Inc. [ADXS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.43. With this latest performance, ADXS shares gained by 1.54% in over the last four-week period, additionally sinking by -37.51% over the last 6 months – not to mention a rise of 23.79% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ADXS stock in for the last two-week period is set at 41.46, with the RSI for the last a single of trading hit 43.54, and the three-weeks RSI is set at 44.75 for Advaxis Inc. [ADXS]. The present Moving Average for the last 50 days of trading for this stock 0.6301, while it was recorded at 0.5844 for the last single week of trading, and 0.6759 for the last 200 days.
Advaxis Inc. [ADXS]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Advaxis Inc. [ADXS] shares currently have an operating margin of -75.02. Advaxis Inc.’s Net Margin is presently recorded at -79.54.
Return on Total Capital for ADXS is now -49.28, given the latest momentum, and Return on Invested Capital for the company is -52.25. Return on Equity for this stock declined to -52.25, with Return on Assets sitting at -30.90.
Reflecting on the efficiency of the workforce at the company, Advaxis Inc. [ADXS] managed to generate an average of -$474,629 per employee.Advaxis Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.50 and a Current Ratio set at 7.50.
Earnings analysis for Advaxis Inc. [ADXS]
With the latest financial reports released by the company, Advaxis Inc. posted -0.96/share EPS, while the average EPS was predicted by analysts to be reported at -1.32/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 27.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ADXS.
Insider trade positions for Advaxis Inc. [ADXS]
There are presently around $4 million, or 19.40% of ADXS stock, in the hands of institutional investors. The top three institutional holders of ADXS stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 3,610,419, which is approximately -4.488% of the company’s market cap and around 0.47% of the total institutional ownership; BLACKROCK INC., holding 847,098 shares of the stock with an approximate value of $0.49 million in ADXS stocks shares; and VANGUARD GROUP INC, currently with $0.46 million in ADXS stock with ownership of nearly 283.683% of the company’s market capitalization.
Positions in Advaxis Inc. stocks held by institutional investors increased at the end of June and at the time of the June reporting period, where 17 institutional holders increased their position in Advaxis Inc. [NASDAQ:ADXS] by around 1,644,166 shares. Additionally, 11 investors decreased positions by around 1,170,442 shares, while 11 investors held positions by with 4,110,444 shares. The mentioned changes placed institutional holdings at 6,925,052 shares, according to the latest SEC report filing. ADXS stock had 6 new institutional investments in for a total of 90,396 shares, while 7 institutional investors sold positions of 966,071 shares during the same period.